Concepedia

Sarah Palackdharry

SP

Statistics

Publications

11

Citations

404

H-Index

11

Active since

2016

Affiliations

University of Cincinnati Medical Center(Current)

University of Cincinnati

University of Michigan

Cincinnati Children's Hospital Medical Center

The University of Texas MD Anderson Cancer Center

Sarah Palackdharry is an author at University of Cincinnati Medical Center specializing in medicine, radiation oncology, and immunology.

ORCID

Top concepts

Publications per year

2016–2023

11

Publications

11

Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models

Christina A. Wicker, Brian G. Hunt, Sunil Krishnan et al. · Cancer Letters · 2021 · 87 citations · Full text

, , +9

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition

McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry et al. · Journal for ImmunoTherapy of Cancer · 2022 · 63 citations · Full text

Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma.

Trisha M. Wise‐Draper, Matthew Old, Francis P. Worden et al. · Journal of Clinical Oncology · 2018 · 56 citations

, , +24

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Shuchi Gulati, Janki Desai, Sarah Palackdharry et al. · Cancer · 2019 · 42 citations · Full text

Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC).

Trisha M. Wise‐Draper, Vinita Takiar, Michelle Mierzwa et al. · Journal of Clinical Oncology · 2021 · 35 citations

, , +24

1–5 of 11